BSX
Boston Scientific Corp
NYSE: BSX · HEALTHCARE · MEDICAL DEVICES
$57.61
+0.80% today
Updated 2026-04-29
Market cap
$85.62B
P/E ratio
24.10
P/S ratio
4.15x
EPS (TTM)
$2.39
Dividend yield
—
52W range
$56 – $110
Volume
15.7M
WallStSmart proprietary scores
71
out of 100
Grade: B
Buy
Investment rating
8.0
Growth
A5.5
Quality
C+7.0
Profitability
B+5.3
Valuation
C+4/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$85.19
+47.87%
12-Month target
$58.31
+1.22%
Intrinsic (DCF)
$46.04
Margin of safety
-25.13%
10 Strong Buy24 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $1.01B — positive
+ Revenue growth 11.60% QoQ
Risks
- 25.13% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $12.68B | $14.24B | $16.75B | $20.07B | $20.61B | $22.5B |
| Net income | $698.00M | $1.59B | $1.85B | $2.89B | $1.34B | — |
| EPS | — | — | — | — | $2.39 | $3.50 |
| Free cash flow | $914.00M | $1.70B | $2.65B | $3.66B | $1.01B | — |
| Profit margin | 5.50% | 11.19% | 11.07% | 14.38% | 17.30% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-02 | WEBER, CHRISTOPHE PIERRE | Buy | 556 | — |
| 2026-03-02 | WEBER, CHRISTOPHE PIERRE | Buy | 323 | — |
| 2026-03-02 | SMITH, CATHY R | Buy | 556 | — |
Peer comparison
Smart narrative
Boston Scientific Corp trades at $57.61. representing a P/E of 24.10x trailing earnings. Our Smart Value Score of 71/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. TTM revenue stands at $20.61B. with profit margins at 17.30%. Our DCF model estimates intrinsic value at $46.04.
Frequently asked questions
What is Boston Scientific Corp's stock price?
Boston Scientific Corp (BSX) trades at $57.61.
Is Boston Scientific Corp overvalued?
Smart Value Score 71/100 (Grade B, Buy). DCF value $46.04.
What is the price target of Boston Scientific Corp (BSX)?
The analyst target price is $85.19, representing +47.9% upside from the current price of $57.61.
What is the intrinsic value of Boston Scientific Corp (BSX)?
Based on our DCF model, intrinsic value is $46.04, a -25.1% margin of safety versus $57.61.
What is the future stock price of BSX by 2030?
Our research-backed model estimates Boston Scientific Corp could reach $263.84 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Boston Scientific Corp's revenue?
TTM revenue is $20.61B.
Piotroski F-Score?
4/9 — moderate financial health.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio4.15x
ROE12.40%
Beta0.78
50D MA$67.33
200D MA$90.23
Shares out1.49B
Float1.48B
Short ratio—
Avg volume15.7M
Performance
1 week-7.93%
1 month-7.82%
3 months-38.90%
YTD-40.06%
1 year—
3 years—
5 years—